ForSight VISION5, Inc.

ForSight VISION5, Inc.

ForSight VISION5, Inc.

Overview
Date Founded

2010

Headquarters

5 Giralda Farms,Madison, NJ 07940

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Wholesale: Medical Supplies & Pharmaceuticals
Hospitals & Patient Services
Other Business & Consulting Services
Medical Support Services
Medical Products & Equipment
Industrial Machinery & Manufacturing
Electrical Products

Company Description

ForSight VISION5, Inc. develops ocular drug delivery technologies and device solutions for ophthalmic diseases. It engages in the development of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. Its lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to continually receive their medication. The company was founded by Eugene de Juan Jr., J. Andrew Corley and K. Angela Macfarlane in 2010 and is headquartered in Madison, NJ.

Executives & Employees

Vice President, Clinical Research

Executive Officer

Paths to ForSight VISION5, Inc.
Potential Connections via
Relationship Science
You
ForSight VISION5, Inc.
Recent Transactions
Details Hidden

Allergan Ltd. (Ireland) purchases ForSight VISION5, Inc. from Versant Venture Management LLC, Technology Partners, Delphi Ventures, Inc., Morgenthaler Management Corp., H.I.G. BioHealth Partners LLC

Details Hidden

ForSight VISION5, Inc. raised money in a private placement transaction

Details Hidden

ForSight VISION5, Inc. raised money in a private placement transaction

Transaction Advisors
Legal Advisor

Advised onAllergan Ltd. (Ireland) purchases ForSight VISION5, Inc. from Versant Venture Management LLC, Technology Partners, Delphi Ventures, Inc., Morgenthaler Management Corp., H.I.G. BioHealth Partners LLC

Advisors & Consultants
Advisor

Clinical & Regulatory Affairs at Sight Sciences, Inc.

Publicist

Founder at In-Site Communications, Inc.

Investors
Details Hidden

Former Executive Officer & Promoter at eyeBrain Medical, Inc.

Details Hidden

Technology Partners is an active manager which invests in technology companies located in the US. The firm participates in seed, early, and later-stage capital requirements with an investment size of USD 1 to 8 million per round & up to USD 25 million per company.

Details Hidden

Split Rock focuses on leading investments in early-stage medical device companies. They also consider investments in select life sciences opportunities in which they can facilitate additional growth, spin-outs or restructurings. The firm seeks companies with significant market size, usually greater than $500 million. They also look for companies operating in target markets that have the potential to reach over $1 billion over time. Companies should be able to generate $100 million in revenue within 5 years and have gross margins greater than 50%, potential operating margins greater than 20%, recurring revenue streams, capital-efficient growth plans, efficient methods of customer acquisition and sustainable competitive advantages.Split Rock invests Internet and software-driven companies with products that are delivered as on-demand services, premise-based software and appliances. The firm is particularly interested in web-based business and consumer services, marketing automation, enterprise analytics, real-time information services and enterprise infrastructure.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by ForSight VISION5, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of ForSight VISION5, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and ForSight VISION5, Inc..